|Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer|
RR Raval, AB Sharabi, AJ Walker, CG Drake, P Sharma
Journal for immunotherapy of cancer 2 (1), 1-11, 2014
|Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression?|
AJ Walker, J Ruzevick, AA Malayeri, D Rigamonti, M Lim, KJ Redmond, ...
Future Oncology 10 (7), 1277-1297, 2014
|FDA approval of palbociclib in combination with fulvestrant for the treatment of hormone receptor–positive, HER2-negative metastatic breast cancer|
AJ Walker, S Wedam, L Amiri-Kordestani, E Bloomquist, S Tang, ...
Clinical Cancer Research 22 (20), 4968-4972, 2016
|Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2|
CM Annunziata, AJ Walker, L Minasian, M Yu, H Kotz, BJ Wood, K Calvo, ...
Clinical Cancer Research 16 (2), 664-672, 2010
|Results of the 2013-2015 association of residents in radiation oncology survey of chief residents in the United States|
N Nabavizadeh, LM Burt, BR Mancini, ZS Morris, AJ Walker, SM Miller, ...
International Journal of Radiation Oncology* Biology* Physics 94 (2), 228-234, 2016
|L‐asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer|
M Yu, R Henning, A Walker, G Kim, A Perroy, R Alessandro, V Virador, ...
Journal of cellular and molecular medicine 16 (10), 2369-2378, 2012
|US food and drug administration approval: neratinib for the extended adjuvant treatment of early-stage HER2-positive breast cancer|
H Singh, AJ Walker, L Amiri-Kordestani, J Cheng, S Tang, P Balcazar, ...
Clinical Cancer Research 24 (15), 3486-3491, 2018
|Radiation-induced fibrosis: mechanisms and opportunities to mitigate. Report of an NCI workshop, September 19, 2016.|
DE Citrin, PGS Prasanna, AJ Walker, ML Freeman, I Eke, ...
Radiation research 188 (1), 1-20, 2017
|Molecularly targeted agents as radiosensitizers in cancer therapy—focus on prostate cancer|
S Alcorn, AJ Walker, N Gandhi, A Narang, AT Wild, RK Hales, JM Herman, ...
International journal of molecular sciences 14 (7), 14800-14832, 2013
|Correlation of clinical stage and performance status with quality of life in patients seen in a pancreas multidisciplinary clinic|
S Moningi, AJ Walker, CC Hsu, JB Reese, JY Wang, KY Fan, LM Rosati, ...
Journal of oncology practice 11 (2), e216-e221, 2015
|A phase II clinical trial of polyethylene glycol-conjugated L-asparaginase in patients with advanced ovarian cancer: Early closure for safety|
JL Hays, G Kim, A Walker, CM Annunziata, JM Lee, J Squires, N Houston, ...
Molecular and clinical oncology 1 (3), 565-569, 2013
|The use of subcutaneous omeprazole in the treatment of dyspepsia in palliative care patients|
M Agar, R Webster, J Lacey, B Donovan, A Walker
Journal of pain and symptom management 28 (6), 529-531, 2004
|Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy|
MP Huynh-Le, AJ Walker, PC Burger, GI Jallo, KJ Cohen, MD Wharam, ...
Child's Nervous System 32 (8), 1425-1430, 2016
|Clinical development of novel drug–radiotherapy combinations|
SS Ahmad, MR Crittenden, PT Tran, PG Kluetz, GM Blumenthal, ...
Clinical Cancer Research 25 (5), 1455-1461, 2019
|Analysis of fiducials implanted during EUS for patients with localized rectal cancer receiving high-dose rate endorectal brachytherapy|
S Moningi, AJ Walker, AA Malayeri, LM Rosati, SL Gearhart, JE Efron, ...
Gastrointestinal endoscopy 81 (3), 765-769. e1, 2015
|An integrated program in a pandemic: Johns Hopkins radiation oncology department|
JL Wright, SR Alcorn, T McNutt, S Han-Oh, R Gonzalez, L Lin, R Anderson, ...
Advances in radiation oncology 5 (4), 666, 2020
|Use of standardized uptake value thresholding for target volume delineation in pediatric Hodgkin lymphoma|
AJ Walker, A Chirindel, RF Hobbs, MP Huynh-Le, JA Moore, SY Cho, ...
Practical radiation oncology 5 (4), 219-227, 2015
|Concurrent immunotherapy and stereotactic radiosurgery for brain metastases is associated with a decreased incidence of new intracranial metastases|
L Chen, J Douglass, AJ Walker, AE Marciscano, M Lim, LR Kleinberg, ...
International Journal of Radiation Oncology• Biology• Physics 93 (3), E102, 2015
|Defining the landscape of ATP-competitive inhibitor resistance residues in protein kinases|
NS Persky, D Hernandez, M Do Carmo, L Brenan, O Cohen, S Kitajima, ...
Nature structural & molecular biology 27 (1), 92-104, 2020
|Clinical development of cancer drugs in combination with external beam radiation therapy: US Food and Drug Administration perspective|
AJ Walker, H Kim, H Saber, PG Kluetz, G Kim, R Pazdur
International Journal of Radiation Oncology• Biology• Physics 98 (1), 5-7, 2017